aldosterone has been researched along with torsemide in 11 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 4 (36.36) | 18.2507 |
| 2000's | 4 (36.36) | 29.6817 |
| 2010's | 2 (18.18) | 24.3611 |
| 2020's | 1 (9.09) | 2.80 |
| Authors | Studies |
|---|---|
| Kido, H; Nishikawa, M; Ohtaki, Y; Uchida, T; Watanabe, M; Yamanaga, K | 1 |
| Kido, H; Ohtaki, Y; Uchida, T; Watanabe, M; Yamanaga, K | 1 |
| Beck, FX; Müller, E; Ohno, A; Pfaller, W; Seppi, T | 1 |
| Bähr, V; Ball, DL; Goodfriend, TL; Oelkers, W | 1 |
| Akutagawa, O; Fukuda, M; Hayashi, T; Honda, K; Okamoto, M; Sasaki, T; Yamato, M | 1 |
| Dohke, T; Fujii, M; Horie, M; Ishikawa, C; Ohno, K; Sakai, H; Takayama, T; Tsutamoto, T; Wada, A; Yamamoto, T | 1 |
| Yamamoto, T; Yano, M | 1 |
| Cheng, XW; Harada, K; Hirashiki, A; Isobe, S; Izawa, H; Kobayashi, M; Murase, Y; Murohara, T; Nagata, K; Nishizawa, T; Noda, A; Yokota, M | 1 |
| Alvarez de la Rosa, D; El Moghrabi, S; Gravez, B; Jaisser, F; Jimenez-Canino, R; Messaoudi, S; Tarjus, A | 1 |
| Adam, O; Böhm, M; Hanke, N; Hartmann, RW; Klemmer, B; Laufs, U; Zimmer, C | 1 |
| Broeckx, BJG; de Salazar Alcala, AG; Devreese, M; Hellemans, A; Paepe, D; Roche-Catholy, M; Schneider, M; Smets, P; Woehrlé, F | 1 |
1 review(s) available for aldosterone and torsemide
| Article | Year |
|---|---|
[Aldosterone antagonist therapy for chronic heart failure].
Topics: Aldosterone; Chronic Disease; Death, Sudden, Cardiac; Diuretics; Eplerenone; Fibrosis; Heart Failure; Humans; Mineralocorticoid Receptor Antagonists; Myocardium; Randomized Controlled Trials as Topic; Spironolactone; Sulfonamides; Torsemide; Ventricular Remodeling | 2005 |
3 trial(s) available for aldosterone and torsemide
| Article | Year |
|---|---|
Effects of torasemide on left ventricular function and neurohumoral factors in patients with chronic heart failure.
Topics: Aged; Aldosterone; Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Echocardiography, Doppler; Female; Follow-Up Studies; Furosemide; Heart Failure; Hemodynamics; Humans; Male; Middle Aged; Neurotransmitter Agents; Regression Analysis; Sulfonamides; Torsemide; Ventricular Dysfunction, Left | 2003 |
Torasemide inhibits transcardiac extraction of aldosterone in patients with congestive heart failure.
Topics: Aldosterone; Diuretics; Female; Furosemide; Heart; Heart Failure; Humans; Male; Middle Aged; Mineralocorticoid Receptor Antagonists; Myocardium; Sulfonamides; Torsemide | 2004 |
Beneficial effects of torasemide on systolic wall stress and sympathetic nervous activity in asymptomatic or mildly symptomatic patients with heart failure: comparison with azosemide.
Topics: Administration, Oral; Aldosterone; Cross-Over Studies; Delayed-Action Preparations; Drug Administration Schedule; Female; Heart Failure; Humans; Male; Middle Aged; Mineralocorticoid Receptor Antagonists; Norepinephrine; Sodium Potassium Chloride Symporter Inhibitors; Sulfanilamides; Sulfonamides; Sympathetic Nervous System; Systole; Torsemide; Ventricular Dysfunction, Left | 2009 |
7 other study(ies) available for aldosterone and torsemide
| Article | Year |
|---|---|
Anti-aldosteronergic effect of torasemide.
Topics: Administration, Oral; Aldosterone; Animals; Diuretics; Furosemide; Male; Rats; Rats, Inbred Strains; Renin; Sulfonamides; Torsemide | 1991 |
Diuretic and vasodilating actions of torasemide.
Topics: Aldosterone; Animals; Desoxycorticosterone; Diuretics; Furosemide; In Vitro Techniques; Male; Potassium; Rats; Rats, Wistar; Renin; Sulfonamides; Torsemide; Vasodilator Agents | 1994 |
Inhibition of angiotensin-converting enzyme modulates structural and functional adaptation to loop diuretic-induced diuresis.
Topics: Aldosterone; Anesthesia; Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Animals; Body Weight; Consciousness; Diuresis; Diuretics; Electrolytes; Enalapril; Hematocrit; Kidney Cortex; Kidney Function Tests; Kidney Tubules; Male; Rats; Rats, Wistar; Rubidium; Sodium; Sodium-Potassium-Exchanging ATPase; Sulfonamides; Torsemide; Urine; Vasoconstrictor Agents; Water-Electrolyte Balance | 1997 |
Torsemide inhibits aldosterone secretion in vitro.
Topics: Aldosterone; Animals; Cattle; Diuretics; Dose-Response Relationship, Drug; Furosemide; Guinea Pigs; Rats; Sulfonamides; Torsemide; Zona Glomerulosa | 1998 |
The diuretic torasemide does not prevent aldosterone-mediated mineralocorticoid receptor activation in cardiomyocytes.
Topics: Active Transport, Cell Nucleus; Aldosterone; Animals; Cell Nucleus; Chlorocebus aethiops; COS Cells; Diuretics; Green Fluorescent Proteins; Humans; Immediate-Early Proteins; Luciferases; Mice; Microscopy, Confocal; Mineralocorticoid Receptor Antagonists; Myocytes, Cardiac; Orosomucoid; Plasminogen Activator Inhibitor 1; Protein Serine-Threonine Kinases; Rats; Receptors, Mineralocorticoid; Reverse Transcriptase Polymerase Chain Reaction; Serpins; Spironolactone; Sulfonamides; Tenascin; Torsemide; Transcriptional Activation | 2013 |
Inhibition of aldosterone synthase (CYP11B2) by torasemide prevents atrial fibrosis and atrial fibrillation in mice.
Topics: Aldosterone; Animals; Atrial Fibrillation; Atrial Remodeling; Cardiotonic Agents; Cells, Cultured; Connective Tissue Growth Factor; Cytochrome P-450 CYP11B2; Drug Evaluation, Preclinical; Fibrillar Collagens; Fibroblasts; Fibrosis; Inhibitory Concentration 50; Mice; Mice, Transgenic; MicroRNAs; Protein-Lysine 6-Oxidase; Rats, Sprague-Dawley; Sulfonamides; Torsemide | 2015 |
Pharmacokinetic and pharmacodynamic properties of orally administered torasemide in healthy cats.
Topics: Aldosterone; Animals; Cats; Creatinine; Diuretics; Dogs; Electrolytes; Furosemide; Humans; Potassium; Sodium; Sulfonamides; Torsemide | 2022 |